Viewing Study NCT04819269

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:11 PM
Ignite Modification Date: 2026-03-05 @ 4:27 PM
Study NCT ID: NCT04819269
Status: COMPLETED
Last Update Posted: 2024-02-20
First Post: 2021-03-24
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Tivanisiran for Dry Eye in Subjects With Sjögren's Syndrome
Sponsor: Sylentis, S.A.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Dry Eye Disease View
None Sjögren Syndrome View
Keywords:

Keywords

Keyword Brief Keyword Text View
None oligonucleotide View
None siRNA View
None keratoconjunctivitis sicca View
None SYL1001 View